Victoria P. Werth, MD
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Headshot of Victoria P. Werth, MD
Penn Medicine Provider

About me

  • Chief, Dermatology, Philadelphia V.A. Hospital
  • Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
  • Professor of Dermatology in Medicine

Education and training

  • Medical School: Johns Hopkins University School of Medicine
  • Residency: Northwestern Medical Center
  • Residency: New York University School of Medicine

What my patients think about me

Average Rating

646 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
March 2026
attentive, looks over the labs or clinical information not just skin issues; but also goes quickly through everything which made it difficult to process and ask pertinent questions. just the wait once in the room to be seen by ma/provider was long but it's expected and not a huge deal
Anonymous
March 2026
dr. werth has a very good bedside manner and is very knowledgeable about my health condition.
Anonymous
March 2026
dr. werth is kind and patient. she has a way of explaining the problem and making one feel at ease.
Anonymous
March 2026
knowledge, kind, professional

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Werth is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, … Werth VP International development of Investigator Global Assessment scores for pemphigus , J Eur Acad Dermatol Venereol: 2026


Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus , J Rheumatol, 53(3): 2026,292-296


Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators A Phase 3 Trial of Brepocitinib in Dermatomyositis , N Engl J Med: 2026


Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials , J Inflamm Res: 2026


Khosravi-Hafshejani T, Ali H, Lopes Almeida Gomes L, Werth VP Environmental Exposures of Concern for Rheumatologists: Ultraviolet Radiation , Rheum Dis Clin North Am, 52(1): 2026,103-119


Baniel A, Momohara-Ogawa M, Bahir M, Pandya R, Kleitsch J, Chin F, Vijayarangan N, Cohen S, Johnson C, Fazelinia H, Spruce L, Werth VP Dysregulated Pathways and Potential Biomarkers in Dermatomyositis Plasma-Derived Extracellular Vesicles - A Pilot Study , J Invest Dermatol, 146(2): 2026,541-544


Korte EWH, Hiel MAJ, Bolling MC, Dunn P, Murrell DF, Werth VP, Yale M, Spuls PI, Meijer JM, Horváth B Navigating challenges in clinical trials for bulbous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey , Br J Dermatol, 194(1): 2026,165-167


Chambers S, Hill A, Yang X, On A, Lopes Ameida Gomes L, Khosravi-Hafshejani T, Ali H, Perez O, Bell S, Donovan C, Adjei T, Werth VP Barriers to clinical trial access among Black lupus patients , Lupus: 2025


Peters ZT, Mendyka LK, Blake J, Goswami HB, Cortez AN, Crossland GE, Shan S, Nowak EC, Mrinal S, Johann EG, Burns CM, Barton DT, Blazar BR, Curiel TJ, Mabaera R, Werth VP, Kalus A, Elkon K, Noelle RJ, Skopelja-Gardner S . Keratinocyte VISTA attenuates UV light-induced skin injury by suppressing cutaneous type I interferon (IFN-I) response , bioRxiv [Preprint]: 2025


Weiner JD, Hill A, Shen C, On A, Werth VP Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review , Lupus Sci Med, 12(2): 2025